Cerus Corporation (CERS) vs NeoGenomics, Inc. (NEO)
A side-by-side comparison of Cerus Corporation and NeoGenomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERS
Cerus Corporation
$2.36HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
NEO
NeoGenomics, Inc.
$16.88HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — CERS vs NEO
growth of $100 · dividends reinvested · last 10yCERS -62.6% (-9.4%/yr)NEO +134.5% (+8.9%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
CERS NEO
CERS vs NEO: by the numbers
- •CERS is the larger company ($475M vs $434M market cap).
- •Both run net losses; CERS's is the smaller (-3.06% vs -6.77% net margin).
- •CERS grew revenue faster over the past five years (15.74% vs 9.41% CAGR).
Metrics side by side
Valuation
| Metric | CERS | NEO |
|---|---|---|
| Forward P/E | N/A | 92.37 |
| P/S ratio | 2.15 | 0.57 |
| P/B ratio | 6.79 | 0.55 |
| EV / EBITDA | 8095.10 | N/A |
Profitability
| Metric | CERS | NEO |
|---|---|---|
| Gross margin | 52.05% | 42.92% |
| Operating margin | -0.73% | -8.63% |
| Net margin | -3.06% | -6.77% |
| ROE | -9.69% | -6.60% |
| ROIC | -1.08% | -5.29% |
Growth (annualized)
| Metric | CERS | NEO |
|---|---|---|
| Revenue CAGR (5Y) | 15.74% | 9.41% |
| Total return CAGR (5Y) | -17.30% | -15.14% |
Frequently asked
- Which has grown faster, CERS or NEO?
- Over the past five years, CERS grew revenue faster — CERS at a 15.74% CAGR versus NEO at 9.41%.
- How have CERS and NEO total returns compared?
- Over the past 10 years, CERS delivered -9.37% and NEO delivered 8.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cerus ROENeoGenomics ROECerus operating marginNeoGenomics operating marginCerus revenue growthNeoGenomics revenue growthCerus free cash flowNeoGenomics free cash flow
Cerus & NeoGenomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.